Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schnurr

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Digestive Diseases and Sciences|May 27, 2020
To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic PostconditioningJulia Schewe, Marie-Christine Makeschin, Andrej Khandoga, et al.
Gut|May 6, 2010
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasomeChristian Bauer, Peter Duewell, Christine Mayer, et al.
Blood|November 13, 2007
P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cellsAmanda Shin, Tracey Toy, Simon Rothenfusser, et al.
Canadian Journal of Gastroenterology & Hepatology|July 9, 2019
Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm IschemiaJulia Schewe, Marie-Christine Makeschin, Ingrid Liss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2014
Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvantNicholas S Wilson, Peter Duewell, Becky Yang, et al.
International Journal of Cancer|January 6, 2011
CD103 is a hallmark of tumor-infiltrating regulatory T cellsDavid Anz, Wolfgang Mueller, Michaela Golic, et al.
The American Journal of Pathology|April 24, 2010
4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr miceOnkar P Kulkarni, Sufyan G Sayyed, Claudia Kantner, et al.
International Journal of Cancer|May 18, 2010
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinomaCollin Jacobs, Peter Duewell, Klaus Heckelsmiller, et al.
Journal of the National Cancer Institute|June 25, 2015
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell TherapySebastian Kobold, Simon Grassmann, Michael Chaloupka, et al.
JCI Insight|March 9, 2018
Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gutRachel Mak'Anyengo, Peter Duewell, Cornelia Reichl, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Digestive Diseases and Sciences|May 27, 2020
To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic PostconditioningJulia Schewe, Marie-Christine Makeschin, Andrej Khandoga, et al.
Gut|May 6, 2010
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasomeChristian Bauer, Peter Duewell, Christine Mayer, et al.
Blood|November 13, 2007
P2Y receptor signaling regulates phenotype and IFN-alpha secretion of human plasmacytoid dendritic cellsAmanda Shin, Tracey Toy, Simon Rothenfusser, et al.
Canadian Journal of Gastroenterology & Hepatology|July 9, 2019
Ischemic Postconditioning (IPostC) Protects Fibrotic and Cirrhotic Rat Livers after Warm IschemiaJulia Schewe, Marie-Christine Makeschin, Ingrid Liss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2014
Inflammasome-dependent and -independent IL-18 production mediates immunity to the ISCOMATRIX adjuvantNicholas S Wilson, Peter Duewell, Becky Yang, et al.
International Journal of Cancer|January 6, 2011
CD103 is a hallmark of tumor-infiltrating regulatory T cellsDavid Anz, Wolfgang Mueller, Michaela Golic, et al.
The American Journal of Pathology|April 24, 2010
4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr miceOnkar P Kulkarni, Sufyan G Sayyed, Claudia Kantner, et al.
International Journal of Cancer|May 18, 2010
An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinomaCollin Jacobs, Peter Duewell, Klaus Heckelsmiller, et al.
Journal of the National Cancer Institute|June 25, 2015
Impact of a New Fusion Receptor on PD-1-Mediated Immunosuppression in Adoptive T Cell TherapySebastian Kobold, Simon Grassmann, Michael Chaloupka, et al.
JCI Insight|March 9, 2018
Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gutRachel Mak'Anyengo, Peter Duewell, Cornelia Reichl, et al.
Pageof 7